This via a Bloomberg piece from GS:
- "The consensus view of investors is cyclicals will outperform when a vaccine is identified," the strategists wrote. "However, the correlation of returns with the prospects for a vaccine suggest value rather than cyclicals is the better tactical expression of this view."
As for timing, this:
- Vaccine catalysts may coincide with the upcoming U.S. election, which may also provide a tailwind to value in the near term, the strategists said.
Here is the Bloomberg link for more
